Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910392 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xiaoyu Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China. Hauptthemen laut MEDLINE: Rutin, Amyotrophic Lateral Sclerosis, Superoxide Dismutase-1, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Priority Research Program of Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of motor neurons, with limited effective treatments. Recently, the exploration of natural products has unveiled their potential in exerting neuroprotective effects, offering a promising avenue for ALS therapy. In this study, the therapeutic effects of rutin, a natural flavonoid glycoside with neuroprotective properties, were evaluated in a superoxide dismutase 1 (SOD1)-G93A mouse model of ALS. We showed that rutin reduced the level of SOD1 aggregation and diminished glial cell activation in spinal cords and brainstems, resulting in significantly improved motor function and motor neuron restoration in SOD1-G93A mice. Our findings indicated that rutin’s multi-targeted approach to SOD1-related pathology makes it a promising candidate for the treatment of ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Ruitian Liu
Förderung
- Strategic Priority Research Program of Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Du, X., Dong, Q., Zhu, J., Li, L., Yu, X., & Liu, R. (2024). Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910392
Vancouver
Du X, Dong Q, Zhu J, Li L, Yu X, Liu R. Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910392
BibTeX
@article{Du2024,
author = {Du, Xiaoyu and Dong, Quanxiu and Zhu, Jie and Li, Lingjie and Yu, Xiaolin and Liu, Ruitian},
title = {Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910392}
}
EUVIMED